Pew Charitable Trusts offer an analysis on approaches state policymakers can take to make naloxone widely available to people at risk of experiencing or witnessing an overdose.

The CSFD welcomes the acknowledgement of cannabis' therapeutic value, recommends more regular reviews and calls for a balanced approach.

Criminalisation, stigmatisation and racism create barriers to access support, worsening health outcomes.

‘Targets’ is a glimpse into a dystopian yet real-world story where women seeking drug dependence treatment are forced into accepting social stigmas and renouncing their maternal rights.

Wolfe and Saucier argue that the success of future biotechnological treatments will rely on how the ethical considerations behind its applications will be addressed.

Thomas D. Brothers et al. examine the encouraging metrics hospitals show in treating those with opioid dependencies and their positive impact after treatment has ended.

Drug policy groups in the US unite to call on the incoming administration to prioritise harm reduction over criminalisation.

The programme provides access to free HCV, HIV and syphilis screenings, counselling and referrals to treatment.

IDPC and a coalition of NGOs provide recommendations to ensure that Nepalese national drug policies respect human rights and fundamental freedoms.

The EMCDDA provides an overview of the pandemic's impact in drug markets, service provision and people who use drugs.

The American Medical Association calls for an expansion of harm reduction efforts to tackle the overdose crisis.

EHRA highlights ten case studies of harm reduction delivery during the pandemic situation.

INCB affirms to the Philippines its zero-tolerance position regarding human rights violations in the name of drug control.

C-EHRN points to the resilience of harm reduction services to highlight their flexibility, resourcefulness and importance for the community.

Women in Mexico suffer abhorrent human rights abuses in unlawful detention centres, which operate in near-total impunity under the guise of treating drug dependence.

EuroNPUD outlines the modalities and comparative benefits of opioid substitution therapies.

EuroNPUD provides guidance on advocating for opioid substitution therapy services the COVID-19 lockdown period.

Iceland becomes the 13th country to implement this effective harm reduction initiative.

Incarceration does not address any of the challenges associated with drug use, but rather compounds them.

The simple possession of small quantities for personal use will no longer be prosecuted, in a move that the government characterises as moving from punishment to 'help'.